Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Intellasys...

Oct 04, 2006 05:01AM

Oct 04, 2006 07:13AM

Oct 04, 2006 07:54AM

Oct 04, 2006 08:10AM
I thought the intellect on this board had come to a conclusion that Intellasys was a subset of TPL and since TPL, as half owners, of the Moore Patent Portfolio can do as they please without paying anything to PTSC. Just as PTSC can do with the technology if they choose to. I also mentioned the concern I had that TPL's conflict of interest may well affect us. I saw BaNosser address that issue on InvestorHub as well. TPL's resources may have different priorities than what we would like to see. Discounts and a wink with a followon order may be the nature of the beast. It's what we can do with our slice of the pie. It's an opportunity to take the proceeds and build a solid, long term great company. That is why the upcoming decisions as to where we go from here are sooo important.
Share
New Message
Please login to post a reply